| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000026257 |
| Receipt No. | R000030100 |
| Official scientific title of the study | The effect of intravenous acetaminophen on postoperative pain control after esophageal cancer surgery, a prospective randomized study. |
| Date of disclosure of the study information | 2017/04/01 |
| Last modified on | 2019/03/01 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The effect of intravenous acetaminophen on postoperative pain control after esophageal cancer surgery, a prospective randomized study. | |
| Title of the study (Brief title) | The effect of intravenous acetaminophen on postoperative pain control after esophageal cancer surgery, a prospective randomized study. | |
| Region |
|
|
| Condition | ||
| Condition | Esophageal cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To prove the efficacy of intravenous acetamonophen on postoperative pain control after esophageal cancer surgery compared with epidural anesthesia alone. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | The frequency of analgesic rescue dose |
| Key secondary outcomes | Side effect of opioid
Pain(until 7 days after surgery) The days until first gait, flatus, and constipation after surgery Hospital stay days after surgery |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Using asetaminophen until 7days after surgery.
4 times per a day, 15mg/kg Combination with epidural anesthesia |
|
| Interventions/Control_2 | Not using asetaminophen.
Only epidural anesthesia |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | a person older than 20 years old
sex dose not matter a person who was informed sufficiently, and agree to participate this study of one's free will |
|||
| Key exclusion criteria | A person who had contraindication about treatment below,
1,Epidural analgesia 2,using acetaminophen 3,using NSAIDs A person who do not agree to participate this study and was unsuitable for this study |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Akira Tangoku |
| Organization | Tokushima university and graduated school, |
| Division name | Thoracic, endocrine oncology and surgery |
| Address | 18-15, Kuramotocho,Tokushima,Japan |
| TEL | 088-633-7173 |
| tangoku@tokushima-u.ac.jp | |
| Public contact | |
| Name of contact person | Takeshi Nishino |
| Organization | Tokushima university and graduated school |
| Division name | Thoracic, endocrine oncology and surgery |
| Address | 18-15, Kuramotocho,Tokushima,Japan |
| TEL | 088-633-7173 |
| Homepage URL | |
| nishinotakeshi@tokushima-u.ac.jp | |
| Sponsor | |
| Institute | Tokushima university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000030100 |